Phadia US Inc.

Portage, MI Immunodiagnostics

UEI
DK4EVCWUNUM4
CAGE
1QNW5
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Foreign Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
4169 Commercial Ave, Portage, MI 49002, USA
Website
thermofisher.com
Founded
1956
Employees
100K+
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Phadia US Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Specific anti-alpha-GAL immunocaptm phadia core laboratory testing phadia US INC:1109918 [26-008249] Contract · 75N98026P01418 Office of Logisitics and Acquisition Operations $22,650
Two (2) fully automated phadia 1000 immunocap system analyzers (lease agreement) for allergy testing results… Contract · HT940826CE017 Defense Health Agency $505,866
Items for laboratory mission. Contract · HT009026FK015 Defense Health Agency $54,857
Allergy testing supplies. Contract · HT009026FK005 Defense Health Agency $68,994
Lab supplies for medical treatment facility Contract · HT009026FJ014 Defense Health Agency $39,917

About Phadia US Inc.

Phadia US Inc. Immunodiagnostics Division is a foreign-owned, for-profit subsidiary of Thermo Fisher Scientific that specializes in advanced allergy and autoimmune testing solutions for federal government agencies. The company provides sophisticated medical diagnostic technologies, particularly focusing on immunological testing equipment, analyzers, reagents, and related technical support services. As a critical provider of scientific instruments, Phadia US Inc. has established itself as a key vendor for military medical facilities, supporting healthcare and research programs across various federal agencies.

Through its federal contract awards, Phadia US Inc. has consistently provided specialized medical diagnostic equipment and services primarily to defense and veterans' healthcare agencies. The company's prime contract awards have predominantly been with the Defense Health Agency, Veterans Integrated Service Networks, and the Army Medical Command, focusing on allergy testing services, in-vitro diagnostic substances, and specialized testing equipment like IMMUNOCAP SPEC IGE and Helios systems. These contracts, which range in value from approximately $25,000 to $596,000, are typically firm-fixed-price purchase orders or Blanket Purchase Agreement (BPA) calls. None of the awards have utilized set-aside designations, indicating open market procurement processes. The company has also performed as a sub-contractor for computing equipment and power supply projects, demonstrating versatility in its federal contract capabilities.

Phadia US Inc. holds two significant federal contract Indefinite Delivery/Indefinite Quantity (IDV) vehicles, both single-award Blanket Purchase Agreements with the Air Force Air Education and Training Command. These BPAs, each valued at $13.8 million and running through April 2026, enable the Air Force to procure IMMUNOCAP SYSTEM ANALYZERS and associated equipment, software, supplies, training, and technical support. These IDVs specifically support medical facilities like the Wilford Hall Ambulatory Surgical Center at JBSA-Lackland, Texas, and provide a flexible mechanism for ordering immunodiagnostic equipment. The BPAs reflect the company's strategic importance in supporting military medical diagnostic capabilities, allowing task orders for specialized allergen-specific IgE antibody testing equipment that supports allergy diagnosis and management across Air Force medical facilities nationwide.

Quick answers

What is Phadia US Inc.'s UEI?

Phadia US Inc.'s Unique Entity ID (UEI) in SAM.gov is DK4EVCWUNUM4.

What is Phadia US Inc.'s CAGE code?

Phadia US Inc.'s CAGE code is 1QNW5.

What is Phadia US Inc.'s primary NAICS code?

Phadia US Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Phadia US Inc. located?

Phadia US Inc.'s physical address in SAM.gov is 4169 Commercial Ave, Portage, MI 49002, USA.

Is Phadia US Inc. registered in SAM.gov?

Yes. Phadia US Inc.'s SAM.gov registration is active through October 6, 2027.

What is Phadia US Inc.'s most recent federal award?

Phadia US Inc.'s most recent federal contract award is Specific anti-alpha-GAL immunocaptm phadia core laboratory testing phadia US INC:1109918 [26-008249] (75N98026P01418), from Office of Logisitics and Acquisition Operations, on August 31, 2026.

On GovTribe

See Phadia US Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors